Insider Selling: Omada Health (NASDAQ:OMDA) CEO Sells $53,228.00 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 2,800 shares of the stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $19.01, for a total value of $53,228.00. Following the sale, the chief executive officer owned 409,061 shares of the company’s stock, valued at $7,776,249.61. This trade represents a 0.68% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Omada Health Price Performance

Shares of NASDAQ OMDA opened at $20.89 on Monday. The stock has a market capitalization of $1.24 billion and a price-to-earnings ratio of -77.37. The stock’s fifty day simple moving average is $16.51 and its 200 day simple moving average is $14.84. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92.

Omada Health (NASDAQ:OMDA) last announced its earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The business had revenue of $78.05 million during the quarter. As a group, analysts anticipate that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Institutional Investors Weigh In On Omada Health

A number of institutional investors have recently modified their holdings of OMDA. Perceptive Advisors LLC acquired a new position in shares of Omada Health in the second quarter worth $44,402,000. Millennium Management LLC boosted its position in Omada Health by 1,195.0% during the fourth quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock valued at $35,855,000 after purchasing an additional 2,096,705 shares during the last quarter. Divisadero Street Capital Management LP acquired a new stake in Omada Health during the third quarter valued at $30,510,000. Jefferies Financial Group Inc. purchased a new position in Omada Health in the fourth quarter valued at about $16,948,000. Finally, SG Americas Securities LLC purchased a new position in Omada Health in the first quarter valued at about $10,401,000.

Analyst Ratings Changes

Several research analysts have commented on OMDA shares. Weiss Ratings upgraded shares of Omada Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday. Needham & Company LLC restated a “buy” rating and set a $28.00 price target on shares of Omada Health in a report on Friday, May 8th. Morgan Stanley restated an “overweight” rating and issued a $30.00 price target on shares of Omada Health in a research report on Monday, June 22nd. JPMorgan Chase & Co. lowered their price objective on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a research report on Thursday, March 12th. Finally, Canaccord Genuity Group set a $24.00 target price on shares of Omada Health in a research note on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Omada Health presently has a consensus rating of “Moderate Buy” and an average target price of $22.91.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.